Patents Represented by Attorney, Agent or Law Firm Karen S. Smith
  • Patent number: 6555116
    Abstract: Thioredoxin, a small dithiol protein, is a specific reductant for allergenic proteins and particularly allergenic proteins present in pollen and animal and plant sources. All targeted proteins contain disulfide (S—S) bonds that are reduced to the sulfhydryl (SH) level by thioredoxin. The proteins are allergenically active and less digestible in the oxidized (S—S) state. When reduced (SH state), they lose their allergenicity and/or become more digestible. Thioredoxin achieved this reduction when activated (reduced) either by NADPH via NADP-thioredoxin reductase (physiological conditions) or by lipoic acid chemical reductant. Skin tests carried out with sensitized dogs showed that treatment of the pollens with reduced thioredoxin prior to injection eliminated or decreased the allergenicity of the pollen. Studies showed increased digestion of the pollen proteins by pepsin following reduction by thioredoxin.
    Type: Grant
    Filed: January 27, 1999
    Date of Patent: April 29, 2003
    Assignee: Regents of the University of California
    Inventors: Bob B. Buchanan, Gregorio del Val, Rosa M. Lozano, Joshua H. Wong, Boihon C. Yee, Oscar L. Frick
  • Patent number: 6372493
    Abstract: Methods are provided for the establishment and maintenance in long term culture of hormone secreting cells. Cells are derived from tumorous or non-tumorous animal or human tissues, including ovary, endometrium, trophoblast, pituitary, thyroid, and pancreas. The cells secrete into the culture medium hormones such as estrogens, progestins, follicle-stimulating hormone, luteinizing hormone, human chorionic gonadotrophin, thyroxin, glucagon, and insulin, depending on the tissue of origin of individual cell cultures. Contact with an appropriate secretogogue causes the cells to respond with increased hormone secretion. For instance, ovarian follicular cells respond to follicle-stimulating hormone with increased estrogen and progesterone secretion. Pancreatic cells respond to elevated glucose with increased insulin secretion. The cells proliferate in in vitro for up to one year or longer, during which time they retain their hormone-secretion profile.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: April 16, 2002
    Assignee: Pacific Biomedical Research, Inc. [Cell Mart, Inc.]
    Inventor: Ann Janice Brothers
  • Patent number: 5869258
    Abstract: Six sets of Salmonella typhimurium strains are provided, all strains having low spontaneous mutation rates, and each set being sensitive to and diagnostic of one of the six possible base substitutions in DNA. Also provided are methods for making and using these S. typhimurium strains to detect, and establish the type of specific base substitution mutation induced by, mutagenic agents.
    Type: Grant
    Filed: May 28, 1997
    Date of Patent: February 9, 1999
    Assignee: The Regents of the University of California
    Inventors: Pauline Gee, Dorothy M. Maron, Bruce N. Ames